Thermo Fisher Scientific Inc (TMO, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals. Thermo Fisher Scientific Inc has a market cap of $122.24 billion; its shares were traded at around $304.85 with a P/E ratio of 33.27 and P/S ratio of 4.81. The dividend yield of Thermo Fisher Scientific Inc stocks is 0.25%. Thermo Fisher Scientific Inc had annual average EBITDA growth of 15.00% over the past ten years. GuruFocus rated Thermo Fisher Scientific Inc the business predictability rank of 5-star.
For the last quarter Thermo Fisher Scientific Inc reported a revenue of $6.8 billion, compared with the revenue of $6.5 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $25.5 billion, an increase of 4.9% from last year. For the complete 30-year financial data, please go here.. For the last five years Thermo Fisher Scientific Inc had an average revenue growth rate of 9.9% a year.
The reported diluted earnings per share was $9.17 for the year, an increase of 26.7% from previous year. Over the last five years Thermo Fisher Scientific Inc had an EPS growth rate of 14% a year. The Thermo Fisher Scientific Inc had a decent operating margin of 16.37%, compared with the operating margin of 15.74% a year before. The 10-year historical median operating margin of Thermo Fisher Scientific Inc is 13.67%. The profitability rank of the company is 9 (out of 10).
At the end of the fiscal year, Thermo Fisher Scientific Inc has the cash and cash equivalents of $2.4 billion, compared with $2.1 billion in the previous year. The long term debt was $17.1 billion, compared with $17.7 billion in the previous year. The interest coverage to the debt is 6.2. Thermo Fisher Scientific Inc has a financial strength rank of 5 (out of 10).
At the current stock price of $304.85, Thermo Fisher Scientific Inc is traded at 56.7% premium to its historical median P/S valuation band of $194.59. The P/S ratio of the stock is 4.81, while the historical median P/S ratio is 3.07. The intrinsic value of the stock is $187.42 a share, according to GuruFocus DCF Calculator. The stock gained 22.02% during the past 12 months.
CEO Recent Trades:
- CEO Marc N Casper sold 30,000 shares of TMO stock on 02/11/2020 at the average price of $337.13. The price of the stock has decreased by 9.57% since.
CFO Recent Trades:
- Sr. VP and CFO Stephen Williamson sold 3,268 shares of TMO stock on 02/03/2020 at the average price of $319.13. The price of the stock has decreased by 4.47% since.
Directors and Officers Recent Trades:
- Director Jim P Manzi sold 4,410 shares of TMO stock on 02/05/2020 at the average price of $332.32. The price of the stock has decreased by 8.27% since.
For the complete 20-year historical financial data of TMO, click here.
